XML 76 R60.htm IDEA: XBRL DOCUMENT v3.23.1
OPERATING SEGMENTS (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
segment
item
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Financial information of reportable segments      
Number of operating units | segment 10    
Number of reportable segments | item 3    
Net sales $ 3,571.6 $ 3,266.7  
Operating Income (Loss) 351.6 254.5  
Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     $ 14,187.8
Operating Income (Loss)     1,562.5
Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     14,187.8
Operating Income (Loss)     1,562.5
Global Industrial      
Financial information of reportable segments      
Net sales 1,709.4 1,565.7  
Global Institutional and Specialty      
Financial information of reportable segments      
Net sales 1,128.8 1,009.4  
Global Healthcare and Life Sciences      
Financial information of reportable segments      
Net sales 379.7 362.8  
Other      
Financial information of reportable segments      
Net sales 330.0 294.0  
Operating segment      
Financial information of reportable segments      
Net sales 3,557.4 3,172.3  
Operating Income (Loss) 349.0 238.5  
Operating segment | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     14,473.1
Operating Income (Loss)     1,612.6
Operating segment | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     14,093.4
Operating Income (Loss)     1,546.3
Operating segment | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (379.7)
Operating Income (Loss)     (66.3)
Operating segment | Global Industrial      
Financial information of reportable segments      
Net sales 1,699.3 1,511.4  
Operating Income (Loss) 215.6 179.9  
Operating segment | Global Industrial | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     6,944.0
Operating Income (Loss)     977.0
Operating segment | Global Industrial | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     6,736.3
Operating Income (Loss)     935.8
Operating segment | Global Industrial | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (207.7)
Operating Income (Loss)     (42.0)
Operating segment | Global Industrial | Purchase Price Adjustments | Segment Changes      
Financial information of reportable segments      
Operating Income (Loss)     0.8
Operating segment | Global Institutional and Specialty      
Financial information of reportable segments      
Net sales 1,126.6 991.3  
Operating Income (Loss) 125.7 108.6  
Operating segment | Global Institutional and Specialty | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     4,480.0
Operating Income (Loss)     634.5
Operating segment | Global Institutional and Specialty | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     4,414.3
Operating Income (Loss)     621.7
Operating segment | Global Institutional and Specialty | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (75.9)
Operating Income (Loss)     (11.2)
Operating segment | Global Institutional and Specialty | Purchase Price Adjustments | Segment Changes      
Financial information of reportable segments      
Net sales     10.2
Operating Income (Loss)     (1.6)
Operating segment | Global Healthcare and Life Sciences      
Financial information of reportable segments      
Net sales 378.6 348.2  
Operating Income (Loss) 35.0 41.9  
Operating segment | Global Healthcare and Life Sciences | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     1,570.0
Operating Income (Loss)     205.0
Operating segment | Global Healthcare and Life Sciences | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     1,505.8
Operating Income (Loss)     193.3
Operating segment | Global Healthcare and Life Sciences | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (64.2)
Operating Income (Loss)     (9.9)
Operating segment | Global Healthcare and Life Sciences | Purchase Price Adjustments | Segment Changes      
Financial information of reportable segments      
Operating Income (Loss)     (1.8)
Operating segment | Other      
Financial information of reportable segments      
Net sales 329.3 286.8  
Operating Income (Loss) 50.1 37.1  
Operating segment | Other | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     1,355.0
Operating Income (Loss)     212.8
Operating segment | Other | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     1,313.3
Operating Income (Loss)     209.9
Operating segment | Other | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (31.5)
Operating Income (Loss)     (5.5)
Operating segment | Other | Purchase Price Adjustments | Segment Changes      
Financial information of reportable segments      
Net sales     (10.2)
Operating Income (Loss)     2.6
Currency impact      
Financial information of reportable segments      
Net sales 14.2 94.4  
Operating Income (Loss) 2.6 16.0  
Currency impact | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     (285.3)
Operating Income (Loss)     (50.1)
Currency impact | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     94.4
Operating Income (Loss)     16.2
Currency impact | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     379.7
Operating Income (Loss)     66.3
Corporate      
Financial information of reportable segments      
Net sales 23.7 34.8  
Operating Income (Loss) (77.4) (129.0)  
Corporate | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales $ 23.6 $ 34.6  
Corporate | Previously Reported | Valued at 2022 Management Rates      
Financial information of reportable segments      
Net sales     124.1
Operating Income (Loss)     (416.7)
Corporate | Previously Reported | Valued at 2023 Management Rates      
Financial information of reportable segments      
Net sales     123.7
Operating Income (Loss)     (414.4)
Corporate | Purchase Price Adjustments | Changes in Currency Rates      
Financial information of reportable segments      
Net sales     (0.4)
Operating Income (Loss)     $ 2.3